2022
Racial and Ethnic Disparities in Financial Barriers Among Overweight and Obese Adults Eligible for Semaglutide in the United States
Lu Y, Liu Y, Krumholz HM. Racial and Ethnic Disparities in Financial Barriers Among Overweight and Obese Adults Eligible for Semaglutide in the United States. Journal Of The American Heart Association 2022, 11: e025545. PMID: 36172953, PMCID: PMC9673703, DOI: 10.1161/jaha.121.025545.Peer-Reviewed Original ResearchConceptsLow family incomeEligible populationUsual sourceHispanic adultsFinancial barriersEthnic disparitiesNutrition Examination Survey 2015Drug Administration labelingCross-sectional analysisFamily incomePercentage of adultsObese adultsNational HealthUS adultsSemaglutideEligibility criteriaSocial determinantsBlack adultsLarge proportionFinal analysisWeight lossHispanic individualsWhite individualsAdultsRisk reduction
2013
When Choosing Statin Therapy: The Case for Generics
Green JB, Ross JS, Jackevicius CA, Shah ND, Krumholz HM. When Choosing Statin Therapy: The Case for Generics. JAMA Internal Medicine 2013, 173: 229-232. PMID: 23303273, DOI: 10.1001/jamainternmed.2013.1529.Commentaries, Editorials and Letters
1999
Under-Utilisation of b-Blockers After Acute Myocardial Infarction
Bradford W, Chen J, Krumholz H. Under-Utilisation of b-Blockers After Acute Myocardial Infarction. PharmacoEconomics 1999, 15: 257-268. PMID: 10537433, DOI: 10.2165/00019053-199915030-00005.Peer-Reviewed Original ResearchConceptsB-blocker therapyB-blockersAcute myocardial infarction survivorsRelative risk reductionAcute myocardial infarctionMyocardial infarction survivorsLess effective treatmentsFirst yearHospital readmissionMyocardial infarctionInfarction survivorsDearth of evidenceEffective treatmentTherapyMedical resourcesRisk reductionHealth statesRecent studiesLittle evidenceAMIUnderprescriptionReinfarctionReadmissionMorbidityInfarction
1997
Guide to primary prevention of cardiovascular diseases. A statement for healthcare professionals from the Task Force on Risk Reduction. American Heart Association Science Advisory and Coordinating Committee.
Grundy S, Balady G, Criqui M, Fletcher G, Greenland P, Hiratzka L, Houston-Miller N, Kris-Etherton P, Krumholz H, LaRosa J, Ockene I, Pearson T, Reed J, Washington R, Smith S. Guide to primary prevention of cardiovascular diseases. A statement for healthcare professionals from the Task Force on Risk Reduction. American Heart Association Science Advisory and Coordinating Committee. Circulation 1997, 95: 2329-31. PMID: 9142014, DOI: 10.1161/01.cir.95.9.2329.Peer-Reviewed Original Research